Table 2 Management of patients with CO-GHD according to each Scottish centre
All centres | A | B | C | D | |
|---|---|---|---|---|---|
Total number of patients (n) | 130 | 70 | 32 | 18 | 10 |
Total number of patients re-tested n (%) | 74/130 (57) | 48/70 (69) | 16/32 (50) | 5/18 (28) | 5/10 (50) |
Persistent GHD n (%) | 61/74 (82) | 43/48 (90) | 12/16 (75) | 1/5 (20) | 5/5 (100) |
Those with persistent GHD who restarted rhGH n (%) | 51/61 (83) | 35/43 (81) | 11/12 (92) | 1/1 (100) | 4/5 (80) |
Total number of patients not-retested n (%) | 56/130 (43) | 22/70 (31) | 16/32 (50) | 13/18 (72) | 5/10 (50) |
Continued adult rhGH therapy without re-testing n (%) | 34/56 (61) | 7/22 (32) | 16/16 (100) | 7/13 (54) | 4/5 (80) |
Lost to follow up whilst on treatment n (%) | 10/56 (18) | 9/22 (41) | 0 | 0 | 1/5 (20) |
Stopped GH, no re-testing required n (%) | 12/56 (21) | 6/22 (27) | 0 | 6/13 (46) | 0 |